Laniquidar

Laniquidar
Clinical data
ATC code none
Identifiers
CAS Number 197509-46-9
PubChem (CID) 6450806
ChemSpider 4953357
UNII K3FRN4DDOY YesY
Chemical and physical data
Formula C37H36N4O3
Molar mass 584.70 g/mol
3D model (Jmol) Interactive image
  (verify)

Laniquidar (INN) is a P-glycoprotein inhibitor undergoing clinical studies for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).[1]

References

  1. Ross DD (2004). "Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome". Best practice & research. Clinical haematology. 17 (4): 641–51. doi:10.1016/j.beha.2004.08.014. PMID 15494300.


This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.